Advancing liver care
Together

Meet the Resolution Therapeutics team at AASLD, Denver to discuss our clinical program.

5–9 November 2026Denver, Colorado
FIND US AT AASLD, DENVER

Booth #2266/Upper-Level Exhibit Hall

MEET THE TEAM
  • Friday 6 November5:00–6:30 PM
  • Saturday 7 November9:30 AM–5:30 PM
  • Sunday 8 November9:30 AM–5:30 PM

THE CLINICAL PROGRAM

A regenerative approach
to liver disease

Resolution Therapeutics is a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage Therapy (RMT) in inflammatory and fibrotic diseases.

Our clinical program uses an autologous engineered regenerative macrophage therapy in development for people with liver cirrhosis who have recovered from a recent hepatic decompensation, and patients with recent-onset medically refractory ascites.

This population has high mortality and no approved therapy restores liver function in decompensated cirrhosis. To modify the disease, an intervention must act on the underlying liver pathology, not only its complications.

RTX001 mechanism of action showing anti-inflammatory and anti-fibrotic pathways

Building on our experience, our next clinical trial HORIZON-RMT will be initiated in 2027; we would like to hear from experienced hepatologists, and clinical trial centers interested in taking part.

OUR CLINICAL PROGRAM

EMERALD is the third clinical trial showing Regenerative Macrophage Therapy benefit with 50+ patients, and is a leading step in our work towards an engineered, scalable therapy for people with advanced liver disease

OPAL and EMERALD clinical program status: fully recruited.

Your perspective
Our next horizon

We are building partnerships across the liver disease community, from academic medical centers, clinical trial sites and community sites, to patient organizations and care providers. Your perspective can help shape what comes next.

Explore partnership

LET’S DISCUSS

01

Patient Needs

Understanding the clinical realities and unmet needs of people living with decompensated cirrhosis.

02

Cell Therapy

Supporting the latest scientific endeavors to bring an autologous cell therapy from development to patients.

03

Partnerships

How we might work together as our clinical program progresses through development.

THE SCIENCE IN DENVER

Join the discussion

Two presentations.
One regenerative approach.

08NOV

LATE-BREAKING POSTER

Publication #5034

Regenerative Macrophage Therapy (RMT) in End-Stage Liver Disease: Early Results from the EMERALD/OPAL Trials

Sunday 8 November 2026 · 1:00–2:00 pm MSTLate Breaking Posters [5034]
Professor Jonathan FallowfieldOPAL and EMERALD trial Chief Investigator · University of Edinburgh, UK

RESOLUTION THERAPEUTICS

Meet our team at AASLD, Denver

6–9 NOVEMBER 2026

Amir Hefni

Chief Executive Officer

Cliff Brass

Chief Medical Officer

Faisal Sheikh

Medical Director

Louise Rowe

VP Strategy and Operations

Camille Perrin

Senior Clinical Project Manager

Lara Campana

Senior VP, Research & Translational Sciences

For any enquiries please reach out: contact@resolution-tx.com

LET’S CONNECT

Start a
conversation

Interested to learn more about RMT as a potential treatment for decompensated cirrhosis?

Tell us how you’d like to connect with the Resolution team.

Meet us at AASLD, request a follow-up call after AASLD The Liver Meeting, or register your interest in a potential study-site partnership.

Not at AASLD this year?

We’d still like to hear from you. Book a video call with our clinical team to discuss opportunities for site participation.

For healthcare professionals and research centers. This form is an expression of interest, not a confirmed appointment or a study-site commitment.

Register your interest

Required fields *

Please provide a few professional details to help us connect.

Professional contact details
I’m interested in

Select all that apply.

Please do not include patient information, health records or other sensitive personal data.

Your details are used to handle this enquiry. Read Resolution Therapeutics’ privacy notice (PDF, opens in a new tab). For privacy enquiries, contact contact@resolution-tx.com.

Professional enquiries only. No patient data.